Grifols

Grifols EBIT Margin

The EBIT Margin (Operating Margin) of Grifols (GRF.MC) as of Sep 17, 2026 is 16.22 %. In the previous year, EBIT Margin (Operating Margin) was 15.88 % — a change of 2.13% (higher).

EBIT Margin

16.22 %

YoY

2.13%

Last updated:

EBIT Margin (Operating Margin) of Grifols is 2026 16.22 % . EBIT Margin (Operating Margin) of Grifols was 2025 15.88 % . It decreases by 2.13% higher compared to the previous year.

Grifols's operating (EBIT) margin stands at 16.2%, up from 12.1% several years earlier.

The Grifols EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
22.16 EUR
Jan 1, 2019
22.39 EUR
Jan 1, 2020
18.65 EUR
Jan 1, 2021
12.06 EUR
Jan 1, 2022
13.29 EUR
Jan 1, 2023
11.19 EUR
Jan 1, 2024
15.88 EUR
Jan 1, 2025
16.22 EUR
The Grifols EBIT Margin history
YEAREBIT MarginYoY
16.22 %+2.13%
15.88 %+41.83%
11.19 %-15.75%
13.29 %+10.14%
12.06 %-35.33%
18.65 %-16.68%
22.39 %+1.04%
22.16 %-1.87%
22.58 %-2.66%
23.20 %-5.95%
24.66 %-3.52%
25.56 %+9,420.59%
0.27 %+6.61%
0.25 %+62.17%
0.16 %-26.62%
0.21 %-14.68%
0.25 %-0.47%
0.25 %+19.77%
0.21 %+34.36%
0.15 %
Access this data via the Eulerpool API

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

EBIT Margin (Operating Margin) of Grifols is 16.22 % in 2026.

EBIT Margin (Operating Margin) of Grifols changed from 15.88 % to 16.22 %, representing a 2.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Grifols since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Grifols with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Grifols

All Key Metrics — Grifols